Physician profile
Brett Arnold
NPI 1821404955
$4,110.84
in general payments reported to CMS, 2019-2025
22 companies · $540 in 2025
The $540 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $426 · 2021: $770 · 2022: $804 · 2023: $519 · 2024: $471 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,529.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $862.08 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $656.00 | 2019-2025 | Tryptyr, Rocklatan, Precision 1 |
| Sun Pharmaceutical Industries INC. | $465.35 | 2019-2025 | Cequa |
| Bausch & Lomb Americas INC. | $281.40 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Coopervision INC. | $221.00 | 2020-2025 | Clariti Contact Lens, Myday Contact Lens |
| Allergan, INC. | $192.58 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $178.72 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $178.44 | 2019-2022 | |
| Dompe US, INC. | $173.15 | 2021-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $162.35 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $142.27 | 2019-2025 | |
| Oyster Point Pharma, INC. | $108.64 | 2023-2025 | Tyrvaya, Ryzumvi |
| Kala Pharmaceuticals, INC. | $103.23 | 2021-2022 | |
| Eyevance Pharmaceuticals LLC | $80.64 | 2021-2022 | |
| Glaukos Corporation | $64.97 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $60.25 | 2019-2020 | |
| Lombart Brothers, INC. | $43.44 | 2021-2022 | |
| Shire North American Group INC | $42.82 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $33.73 | 2020-2021 | |
| Thea Pharma INC. | $20.34 | 2022 | |
| Aerie Pharmaceuticals, INC. | $20.04 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.